Medical device company developing novel therapies for the treatment of joint disease, with an initial focus on osteoarthritis of the knee
Location: United States, California, Hayward
Total raised: $214M
Investors 6
| Date | Name | Website |
| 06.07.2021 | New Enterp... | nea.com |
| - | Gilde Heal... | gildehealt... |
| - | Runway Gro... | runwaygrow... |
| - | Lightstone... | lightstone... |
| - | Advent Lif... | adventls.c... |
| - | Questa Cap... | questacapi... |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 17.08.2024 | Series D | $91M | - |
| 16.08.2022 | - | $40M | - |
| 16.03.2017 | Series C | $50M | New Enterp... |
| 07.05.2015 | Series B | $33M | - |
Mentions in press and media 17
| Date | Title | Description |
| 19.08.2024 | Revolutionizing Healthcare: Moximed and PayZen Lead the Charge | In the evolving landscape of healthcare, two companies are emerging as beacons of innovation: Moximed and PayZen. Both are tackling significant challenges in the medical field, albeit from different angles. Moximed is addressing the physica... |
| 17.08.2024 | Moximed: $91 Million (Series D) Closed To Improve Knee Osteoarthritis Care | Moximed, an innovative medical device company with a goal of improving the standard of care for people with knee osteoarthritis (OA), announced the closing on $61 million of Series D preferred stock financing with an option to close on up t... |
| 16.08.2024 | The Week’s 10 Biggest Funding Rounds: Cybersecurity Leads With Kiteworks’ Nearly Half-Billion-Dollar Deal | 3 Shares Email Facebook Twitter LinkedIn Want to keep track of the largest startup funding deals in 2024 with our curated list of $100 million-plus venture deals to U.S.-based companies? Check out The Crunchbase Megadeals Board. This is a w... |
| 16.08.2022 | Moximed raises $40M for implantable shock absorber for knee osteoarthritis | The Misha implantable shock absorber for the knee [Image from Moximed]Knee osteoarthritis (OA) treatment developer Moximed announced today that it raised $40 million in a Series C equity and debt financing. Fremont, California–based Moximed... |
| 19.03.2017 | Moximed Raises $50M Series C from NEA | Moximed Inc, a developer of unicompartmental load absorber implants for active patients with painful knee osteoarthritis, has raised $50 million in Series C funding. The company’s investors include Advent Life Sciences, Future Fund, NEA, Mo... |
| 16.03.2017 | Moximed Closes Oversubscribed $50MM Financing Round | HAYWARD, California - Moximed®, Inc., developer of unicompartmental load absorber implants for active patients with painful knee osteoarthritis (OA), announced today an oversubscribed Series C round of $50MM with new investors Advent Life S... |
| 16.03.2017 | Moximed Receives $50M Series C Funding | Moximed, Inc., a Hayward, Calif.-based developer of unicompartmental load absorber implants for active patients with painful knee osteoarthritis (OA), received a $50M Series C funding round. Backers included new investors Advent Life Scienc... |
| 08.05.2015 | Vertex Ventures participates in Moximed $33m Series B round | Premium Vertex Ventures , the venture capital arm of Temasek Holdings, has participated in venture funding round organised by medical device company Moximed. This round raised $33 million in private equity investments, with the aim of devel... |
| 08.05.2015 | Moximed closes $33 million financing round | Hayward, California - Moximed®, Inc., developer of the KineSpring® System, a joint unloading knee implant for pre-arthroplasty patients who hope to lead an active lifestyle, announced a round of financing of approximately $33 million that i... |
| 07.05.2015 | Moximed springs to $33m Series B round | Moximed said today that it pulled in a $33 million Series B round for its KineSpring knee implant, which is designed to reduce the load on the joint while sparing its anatomy. The Hayward, Calif.-based company said new backer Vertex Venture... |
Show more